Log in

LON:ODXOmega Diagnostics Group Share Price, Forecast & News

GBX 67
-2.50 (-3.60 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
65.39
Now: GBX 67
73
50-Day Range
11
MA: GBX 45.66
69.50
52-Week Range
6
Now: GBX 67
69.50
Volume2.84 million shs
Average Volume48,651 shs
Market Capitalization£100.87 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Omega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products. The company operates in three segments: Allergy and Autoimmune, Food Intolerance, and Infectious Diseases and Other. The Allergy and Autoimmune segment engages in the research, development, production, and marketing of in-vitro allergy and autoimmune tests used by doctors to diagnose patients with allergies and autoimmune diseases. This segment's principal products include Allergozyme, Allersys, and Genesis Elisa. The Food Intolerance segment engages in the research, development, and production of kits to aid the detection of immune reactions to food under the Genarrayt/Foodprint name. This segment also provides CNS laboratory services that offer clinical analysis to the general public, clinics, and health professionals, as well as supplies Food Detective, a consumer food test. The Infectious Diseases and Other segment is involved in the research, development, production, and marketing of kits that are used in the diagnosis of infectious diseases. Its principal products comprise Immutrep Syphilis, Micropath bacterial tests, and Avitex latex serology tests. The company offers its products to hospitals, blood banks, clinics, and laboratories through distributors in approximately 100 countries worldwide. Omega Diagnostics Group PLC was founded in 1987 and is headquartered in Alva, the United Kingdom.
Read More
Omega Diagnostics Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 1.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.32 out of 5 stars


Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1259-763030

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£9.00 million
Book ValueGBX 13.80 per share

Profitability

Miscellaneous

Employees197
Market Cap£100.87 million
Next Earnings DateN/A
OptionableNot Optionable

Receive ODX News and Ratings via Email

Sign-up to receive the latest news and ratings for ODX and its competitors with MarketBeat's FREE daily newsletter.

Omega Diagnostics Group (LON:ODX) Frequently Asked Questions

How has Omega Diagnostics Group's stock been impacted by COVID-19 (Coronavirus)?

Omega Diagnostics Group's stock was trading at GBX 11.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ODX stock has increased by 495.6% and is now trading at GBX 67. View which stocks have been most impacted by Coronavirus.

Has Omega Diagnostics Group been receiving favorable news coverage?

Media coverage about ODX stock has trended somewhat negative recently, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Omega Diagnostics Group earned a news impact score of -1.1 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news aboutOmega Diagnostics Group.

Who are some of Omega Diagnostics Group's key competitors?

What other stocks do shareholders of Omega Diagnostics Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Omega Diagnostics Group investors own include Cap-XX (CPX), Velocys (VLS), Telford Homes (TEF), Animalcare Group (ANCR), Advanced Medical Solutions Group (AMS), Amgen (AMGN), AEGON (AGN), Adept Technology Group (ADT), ACM Shipping Group (ACMG) and Aurora Cannabis (ACB).

Who are Omega Diagnostics Group's key executives?

Omega Diagnostics Group's management team includes the following people:
  • Mr. Colin King, CEO & Exec. Director (Age 50)
  • Mr. Kieron Antony Harbinson, Group Fin. Director, Company Sec. & Exec. Director (Age 54)
  • Mr. Jag Grewal, Commercial Director & Exec. Director (Age 50)
  • Mr. Andrew William Shepherd, Global Ambassador - Life Pres (Age 63)
  • Mr. Iain Logan, Group Financial Controller

What is Omega Diagnostics Group's stock symbol?

Omega Diagnostics Group trades on the London Stock Exchange (LON) under the ticker symbol "ODX."

How do I buy shares of Omega Diagnostics Group?

Shares of ODX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Omega Diagnostics Group's stock price today?

One share of ODX stock can currently be purchased for approximately GBX 67.

How big of a company is Omega Diagnostics Group?

Omega Diagnostics Group has a market capitalization of £100.87 million and generates £9.00 million in revenue each year. Omega Diagnostics Group employs 197 workers across the globe.

What is Omega Diagnostics Group's official website?

The official website for Omega Diagnostics Group is www.omegadiagnostics.com.

How can I contact Omega Diagnostics Group?

Omega Diagnostics Group's mailing address is Hillfoots Business Village Alva Industrial Estate, ALVA, FK12 5DQ, United Kingdom. The company can be reached via phone at +44-1259-763030.

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.